Skip to main content
Clinical Trials/NCT04089046
NCT04089046
Recruiting
Not Applicable

Telemedicine Enhanced Asthma Management - Uniting Providers for Teens

University of Rochester1 site in 1 country360 target enrollmentFebruary 18, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma in Children
Sponsor
University of Rochester
Enrollment
360
Locations
1
Primary Endpoint
Mean Symptom Free Days in prior 14 days
Status
Recruiting
Last Updated
12 months ago

Overview

Brief Summary

Low-income, minority teenagers have disproportionately high rates of asthma morbidity, including excess risk of emergency department visits, hospitalizations, and death from asthma. Despite well established guidelines, under-treatment for asthma is common, particularly for poor urban teens. This study aims to test a novel, developmentally appropriate and scalable model of care to ensure optimal guideline-based treatment for urban teens with difficult to control asthma. The Telemedicine Enhanced Asthma Management-Uniting Providers for Teens (TEAM-UP for Teens) program includes 3 core components: 1- An individualized asthma management plan developed at the start of the school year via a real-time, synchronous school-based telemedicine visit that directly connects the teen to an asthma specialist, 2- School-based or video supported directly observed therapy (DOT) to implement the medication plan and allow for teens to experience the benefits of consistent therapy, 3- Follow-up telehealth visits with a nurse asthma educator to facilitate ongoing care and provide developmentally appropriate self-management support. This study is a randomized trial of TEAM-UP for Teens vs an enhanced care (EC) control group (n=360, 12-16 years). We will assess the effectiveness of the program in reducing morbidity and improving guideline-based asthma care. Our main hypothesis is that Teens receiving the TEAM-UP for Teens intervention will have more symptom-free days at 3, 5, 7, and 12-months compared to EC. We will assess a number of secondary outcomes, including additional clinical outcomes, functional outcomes, airway inflammation, and receipt of specific care measures including medication adjustments and treatment of and other comorbidities. We will also identify potential mediators and moderators of the intervention effect, and will evaluate the process of intervention implementation. At the completion of the study, the program will be better defined as a sustainable means to improve care and reduce morbidity for high risk teens with difficult to control asthma.

Registry
clinicaltrials.gov
Start Date
February 18, 2021
End Date
June 30, 2027
Last Updated
12 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jill Halterman

Professor

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • Physician-diagnosed asthma (based on caregiver report with validation from teen's physician).
  • Moderate-severe persistent severity (requiring Step 3 or higher care) or asthma that is uncontrolled despite therapy
  • Age \>=12 and =\<17 years
  • Residence in the City of Rochester and surrounding metro area.

Exclusion Criteria

  • Inability to speak and understand either English or Spanish. (\*Participants unable to read will be eligible, and all instruments will be given verbally.)
  • Current participation in an asthma study
  • Planning to move outside of Rochester in less than 6 months
  • If they have received asthma specialist care in the prior 3 months, they will be asked if they would be comfortable seeing an additional asthma specialist for our study if their current specialist is unable to participate in the study. If the family is not comfortable with seeing an additional asthma specialist for the study, they will be excluded.
  • Having other significant medical conditions (congenital heart disease, cystic fibrosis, other chronic lung disease) that could interfere with the assessment of asthma-related measures
  • In foster care or other situations in which consent cannot be obtained from a guardian

Outcomes

Primary Outcomes

Mean Symptom Free Days in prior 14 days

Time Frame: 12-month

Mean Symptom Free Days will be calculated as a mean using data collected at 3-, 5-, 7- and 12-months post baseline. Caregivers and teens will report the number of days the teen experienced no symptoms of asthma (defined as 24 hrs with no coughing, wheezing, shortness of breath, and no need for rescue medicine) in the past 2 weeks (range 0-14).

Study Sites (1)

Loading locations...

Similar Trials